BlackRock Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-53,000
Closed -$2.73M – 3776
2015
Q2
$2.73M Buy
+53,000
New +$2.81M ﹤0.01% 1158

Other funds holding LKFT

BlackRock Advisors's LKFT Position: Q3 2015 in Review

BlackRock Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2015, closing a stake of 53,000 shares — an estimated $2.73M sold.

BlackRock Advisors first reported a position in LKFT in Q2 2015 and held it in 1 quarter. The position peaked at $2.73M in Q2 2015. 38 funds tracked by Wall St. Rank hold LKFT as of Q3 2015.

  • BlackRock Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2015 after selling out during the quarter.
  • BlackRock Advisors sold 53,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2015, an estimated $2.73M.
  • BlackRock Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 1 quarter.
  • BlackRock Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.73M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2015.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.